Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucose Profile”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03534024
What this trial is testing

The Effects of Nanomicelles Curcumin on Glycemic Control, Serum Lipid Profile ,Blood Pressure and Anthropometric Measurements in Patients With Metabolic Syndrome

Who this might be right for
Metabolic Syndrome
National Nutrition and Food Technology Institute 50
Early research (Phase 1)Study completedNCT04771754
What this trial is testing

The Effect of Dolutegravir on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers

Who this might be right for
HIV-1-infection on Healthy Volunteers
Chelsea and Westminster NHS Foundation Trust 16
Not applicableStudy completedNCT03003754
What this trial is testing

Supervised Exercise-training in Children With Insulin Resistance or Healthy Metabolic Profile

Who this might be right for
Metabolism DisorderInsulin SensitivityObesity, Pediatric
Universidad Santo Tomas 60
Not applicableStudy completedNCT03806920
What this trial is testing

Isomaltulose VS Sucrose - Postprandial Effect on Incretin Profile and Second Meal Effect

Who this might be right for
Diabetes Mellitus, Type 2Metabolic Syndrome
German Institute of Human Nutrition 50
Not applicableStudy completedNCT00175084
What this trial is testing

Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers

Who this might be right for
HyperlipidemiasMetabolic Syndrome XCardiovascular Diseases
Tufts University 30
Not applicableStudy completedNCT02438540
What this trial is testing

Comparative the Effect of Metformin and Acupuncture on Weight Loss and Insulin Sensitivity

Who this might be right for
Insulin SensitivityObesity
Amir Firouzjaei 43
Not applicableStudy completedNCT04786925
What this trial is testing

Precision Nutrition Strategies for Improving the Quality of Life of Pre-senior and Senior Populations

Who this might be right for
Overweight or Obesity
Clinica Universidad de Navarra, Universidad de Navarra 126
Not applicableStudy completedNCT05666843
What this trial is testing

Dietary Intervention to Improve Cardiometabolic Risk Profile in Individuals With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Cardiovascular Diseases
Wageningen University 124
Large-scale testing (Phase 3)WithdrawnNCT04057261
What this trial is testing

Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease

Who this might be right for
Type 2 DiabetesCardiovascular Diseases
RWTH Aachen University
Not applicableStudy completedNCT06789263
What this trial is testing

Effect of a Collagen Hydrolysate on Postprandial Blood Glucose Profile, Gastric Emptying and GLP-1 Release in Normoglycemic and Prediabetic Subjects

Who this might be right for
PrediabetesNormoglycemic
Rousselot BVBA 30
Post-approval studies (Phase 4)Ended earlyNCT00640549
What this trial is testing

Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus

Who this might be right for
HyperlipidemiaDiabetes Mellitus, Type 2Non-Insulin Dependent Diabetes Mellitus
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 41
Not applicableStudy completedNCT02093702
What this trial is testing

Impact of Structured Physical Activity Education Delivery in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Royal Victoria Hospital, Canada 5
Early research (Phase 1)Study completedNCT04855292
What this trial is testing

TG103 Injection in Overweight/Obese Subjects Without Diabetes

Who this might be right for
Diabetes
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 48
Not applicableStudy completedNCT03544684
What this trial is testing

Fasted Exercise in People With Type 1 Diabetes

Who this might be right for
Type1diabetes
Liverpool John Moores University 14
Not applicableStudy completedNCT03346746
What this trial is testing

Utilizing GI: Exploring an Optimum Glycaemic Profile for Cognitive Function Across the Day

Who this might be right for
Cognitive PerformanceGlucose, Low BloodGlucose, High Blood+1 more
Matthew Grout 40
Post-approval studies (Phase 4)Study completedNCT01758380
What this trial is testing

Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan

Who this might be right for
Type 2 Diabetes Mellitus
Novartis Pharmaceuticals 557
Not applicableStudy completedNCT01216956
What this trial is testing

Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia

Who this might be right for
Insulin SensitivityLipoproteins MetabolismNon Esterified Fatty Acid Kinetics+1 more
Centre de Recherche en Nutrition Humaine Rhone-Alpe 24
Not applicableStudy completedNCT02157480
What this trial is testing

Effect of Electrostimulation on Glucose Profile of Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesPhysical Activity
University Hospital, Caen 38
Large-scale testing (Phase 3)Study completedNCT01586442
What this trial is testing

Comparison of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes

Who this might be right for
Heart FailureType 2 DiabetesGlucose Intolerance
Montreal Heart Institute 62
Early research (Phase 1)Study completedNCT02201199
What this trial is testing

Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus

Who this might be right for
Type 1 Diabetes Mellitus
Sanofi 36
Next Page